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Eosinophils are predominantly known for their contribution to allergy. Here, we have examined the function and regulation 
of gastrointestinal eosinophils in the steady-state and during infection with Helicobacter pylori or Citrobacter rodentium. 
We find that eosinophils are recruited to sites of infection, directly encounter live bacteria, and activate a signature 
transcriptional program; this applies also to human gastrointestinal eosinophils in humanized mice. The genetic or anti–IL-5–
mediated depletion of eosinophils results in improved control of the infection, increased inflammation, and more pronounced 
Th1 responses. Eosinophils control Th1 responses via the IFN-γ–dependent up-regulation of PD-L1. Furthermore, we find that 
the conditional loss of IFN-γR in eosinophils phenocopies the effects of eosinophil depletion. Eosinophils further possess 
bactericidal properties that require their degranulation and the deployment of extracellular traps. Our results highlight two 
novel functions of this elusive cell type and link it to gastrointestinal homeostasis and anti-bacterial defense.
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bacterially induced gastrointestinal inflammation
Isabelle C. Arnold1, Mariela Artola‑Borán1, Paulino Tallón de Lara2, Andreas Kyburz1, Christian Taube3, Karen Ottemann4, 
Maries van den Broek2, Shida Yousefi5, Hans‑Uwe Simon5, and Anne Müller1
Introduction
Eosinophils arise in the bone marrow (BM) from granulo-
cyte-monocyte progenitors and are released into the circulation 
as terminally differentiated cells, which follow an eotaxin gra-
dient to their target tissues. The differentiation and survivalof 
eosinophils depends on the cytokine IL-5. The tissue distribu-
tion of eosinophils at steady-state is asymmetric, with large 
reservoirs of eosinophils found in the lower gastrointestinal 
(GI) tract, uterus, ovaries, and thymus and few or no eosinophils 
residing in the skin, esophagus, and lungs (Throsby et al., 2000; 
Gouon-Evans and Pollard, 2001; Wu et al., 2011; Chu and Berek, 
2013). The lamina propria (LP) of the GI tract hosts by far the 
most abundant population of resident eosinophils, which com-
prise 20–30% of the total GI LP leukocyte population (Jung and 
Rothenberg, 2014). The presence of eosinophils in the skin and 
lung is generally associated with disease. Eosinophilia is a major 
hallmark of allergic asthma and atopic dermatitis, but is also typ-
ical of chronic inflammatory conditions of the lower GI tract. The 
tissue-damaging and toxic consequences of eosinophilia at these 
sites have been attributed to several factors released by activated 
eosinophils through degranulation, which include eosinophil 
cationic protein (ECP, which forms pores in the membranes of 
target cells), eosinophil peroxidase (EPX; which produces reac-
tive oxygen species such as superoxide, hypobromite, and per-
oxide), and the major basic protein (an enzyme with bactericidal 
and helminthotoxic properties; Lehrer et al., 1989; Rosenberg and 
Dyer, 1995; Rosenberg et al., 2013; Soragni et al., 2015). Eosino-
phils are rapidly recruited to sites of tissue damage in response 
to injury or exposure to pathogens, which directly promotes the 
pathogenesis of inflammatory bowel diseases (McGovern et al., 
1991; Winterkamp et al., 2000; Aydemir et al., 2004; Griseri et 
al., 2015). Whereas the pathogenic properties of eosinophils are 
relatively well understood, less is known about their function in 
the steady-state. Two recent studies have reported that GI eosin-
ophils promote intestinal homeostasis by inducing IgA class 
switching in B cells (Chu et al., 2014), and also by inducing the 
development of Peyer’s patches and enhancing intestinal mucus 
secretion (Jung et al., 2015).
Here, we set out to examine the role of GI tract eosinophils 
in the steady-state as well as during acute or chronic bacterial 
infection. We took advantage of three complementary models of 
eosinophil deficiency, one constitutive and two inducible, in con-
junction with a chronic and an acute infection model using the 
bacterial pathogens Helicobacter pylori and Citrobacter roden-
tium, respectively, to dissect the contribution of eosinophils to GI 
tract homeostasis and to anti-bacterial inflammation and immu-
nity. We found that eosinophils contribute to homeostasis and 
restrict immunopathology by locally suppressing Th1 responses. 
We further show that eosinophils directly encounter live bacteria 
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in the GI LP and demonstrate the bactericidal activity of eosin-
ophils against Citrobacter but not Helicobacter. The results pro-
vide evidence of two novel functions of this versatile cell type and 
further reveal IFN-γ as master regulator of eosinophil activity.
Results
Eosinophil evolution in the GI tract in the steady-state and 
during bacterial infection
The lower GI tract is populated by a large resident pool of eosin-
ophils (Jung and Rothenberg, 2014); in contrast, little is known 
about eosinophils and their function in the upper GI tract. We 
first compared eosinophil numbers and frequencies in the stom-
ach, small intestine, and colon at steady-state and monitored their 
evolution in these organs during the first 8 wk of life. Eosinophils 
were identified in GI LP preparations as live CD45+CD11b+MHC 
II−Ly6G−SiglecF+ cells that constitutively express the chemokine 
receptor CCR3, the IL-5 receptor, F4/80 and CD44 (Fig. S1, A–D). 
Eosinophil frequencies, but not absolute numbers per organ, 
were much higher in the stomach than in the intestines of adult 
mice (Fig. 1 A); the gradual population of the stomach by eosin-
ophils paralleled that of the colon, but not of the small intestine, 
peaked at around the time of weaning, and reached an equilib-
rium in adult animals between 5 and 8 wk of age (Fig. 1 B).
We next investigated the impact of experimental infection of 
the stomach with the gastric pathogen H. pylori on eosinophil 
numbers, frequencies, and phenotype. The number of eosin-
ophils increased fivefold due to the infection and eosinophils, 
along with CD4+ T cells and neutrophils, constituted the numer-
ically dominant leukocyte population in the infected stomach 
(Fig. 1, C–E). Higher eosinophil counts in the infected stomach 
were paralleled by increased eosinophil development in the BM 
and their accumulation in the mesenteric lymph nodes (MLNs; 
Fig. 1, F and G). Eosinophils in the infected stomach were acti-
vated as indicated by their elevated expression of CD11b and 
SiglecF and by their increased granularity relative to eosinophils 
in the steady-state stomach (Fig. 1 H). In contrast, the expression 
of CD63, a marker of eosinophil degranulation, did not change 
(Fig.  1  I). Eosinophils in the infected stomach further showed 
lower rates of Annexin V positivity, which is indicative of their 
extended survival (Fig.  1  J). The transcriptional signature as 
determined by RNA sequencing of sorted, >95% pure eosinophil 
populations clearly segregated eosinophils from infected and 
uninfected stomachs (Fig. 1 K), suggesting that gastric eosino-
phils respond to bacterial infection. Among the most differen-
tially expressed genes were Siglecf and various transcription 
factors such as Irf1, Irf7, Stat1, Stat5a, and Gata1 (Fig. 1 L). Over-
all, the results suggest that eosinophils comprise an abundant 
leukocyte population already in the steady-state stomach, and 
that bacterial infection further augments their numbers as well 
as their activation, which in turn is accompanied by increased 
eosinopoiesis in the BM.
Eosinophil deficiency promotes gastric effector T cell 
responses and immune control of H. pylori
As we had observed sustained accumulation of eosinophils in the 
H. pylori–infected gastric mucosa, we next sought to investigate 
the functional role of eosinophils in this pathological condition 
using two independent approaches to reduce eosinophil num-
bers. First, we continuously administered a neutralizing anti-
body targeting the eosinopoietin IL-5 (Griseri et al., 2015) during 
an 8-wk infection time course. This treatment strongly reduced 
eosinophil frequencies (and as a consequence increased neutro-
phil frequencies) and resulted in increased production of gas-
tric Ifng transcripts and in lower bacterial counts, but did not 
affect Il17 transcript levels (Fig. 2, A–C; and Fig. S2 A). To con-
firm the effects of eosinophil depletion in a second model, we 
infected mice that transgenically express diphtheria toxin under 
the EPX (EPO) promoter, which supports high level expression 
exclusively in eosinophil lineage-committed cells (PHIL mice; 
Lee et al., 2004). PHIL mice were devoid of eosinophils, both in 
the gastric LP (Fig. 2 D and Fig. S2 B) and in all other examined 
tissues (data not shown), but had normal complements of other 
major leukocyte populations (Fig. S2 C). Upon H. pylori infec-
tion, PHIL mice exhibited higher neutrophil infiltration, showed 
increased amounts of gastric mucosal Ifng and Il17 transcripts 
as well as higher Th1 and Th17 cell frequencies, and were colo-
nized at lower levels than their nontransgenic littermates (Fig. 2, 
E–H). The expression of the Th1- and Th17-specific transcrip-
tion factors T-bet and RORγt was increased as well in infected 
PHIL mice (Fig. 2 I). Interestingly, eosinophil deficiency had no 
effect on the expression of the Th2-specific transcription factor 
GATA-3 or on the Th2 cytokines IL-4 and IL-5 (Fig. S2 D). Tran-
script levels of other pro-inflammatory cytokines (TNF-α and 
IL-1β) and anti-microbial enzymes (NOS2) and the eosinophil 
recruiting cytokine eotaxin (CCL11), but not of CCL5 or CSF2, 
were elevated as well (Fig. 2 I and Fig. S2 E). The higher Th1 and 
Th17 cell frequencies of infected PHIL mice were not attributable 
to changes in the regulatory T cell compartment, which was sim-
ilar in PHIL mice and their WT littermates (Fig. S2 F). To prove 
that the phenotype of PHIL mice was linked to their defect in 
eosinophil hematopoiesis, we reconstituted neonatal PHIL mice 
with WT or PHIL BM before infection with H. pylori. As neonatal 
hematopoiesis takes place in the liver, and hematopoietic stem 
cells and colony-forming progenitor cells migrate from liver to 
BM in the first few days of life (Wolber et al., 2002), we chose the 
intrahepatic route for reconstitution. Interestingly, all aspects 
of the phenotype of PHIL mice, i.e., eosinophil deficiency, ele-
vated Th1 responses and reduced H. pylori colonization, were 
reversed by reconstitution of PHIL mice with WT, but not PHIL 
BM (Fig. 2, J–L).
To investigate whether eosinophils and T cells reside in sim-
ilar niches in the H. pylori–infected gastric mucosa, we stained 
sections for both EPX to visualize eosinophils and for CD3 to 
visualize T cells; both populations were found in close proxim-
ity to one another at the base of the glands and throughout the 
infected mucosa and were much more abundant in the infected 
than the uninfected gastric mucosa (Fig. 2 M), thereby confirm-
ing the results of flow cytometric quantification. In summary, the 
ablation of eosinophils results in unrestricted Th1 responses and 
a stronger overall inflammatory reaction to bacterial challenge, 
which in turn promotes bacterial infection control; these results 
indicate that eosinophils have a regulatory rather than pro-in-
flammatory function in this bacterial infection model.
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Eosinophils restrict GI tract T cell responses in the steady-
state to promote mucosal homeostasis
We next sought to elucidate eosinophil functions in the steady-
state GI tract, focusing specifically on T cell responses to the 
normal GI tract microbiota. We quantified transcripts for T cell 
cytokines in the gastric, small intestinal and colonic mucosa of 
PHIL and WT mice. Ifng and Il17, but not Il4 transcripts were 
strongly overexpressed in the colonic and small intestinal 
mucosa of PHIL mice when compared with WT mice (Fig. 3 A), 
indicating a deregulated Th1 and Th17, but not Th2 response in 
the absence of eosinophils. The excessive colonic Th1 and, less 
conclusively, Th17 response of PHIL mice was confirmed by 
intracellular cytokine staining for IFN-γ and IL-17 and by stain-
ing for the transcription factors T-bet and RORγt; GATA-3+ or 
IL-4+ Th2 cells on the other hand did not differ between the two 
strains (Fig. 3, B and C; and Fig. S2 G). We also assessed cyto-
kine production by innate lymphoid cells (ILCs, which we iden-
tified as CD45+ Lin− TCRα/β− CD4− Th1.2+ and IL-7R+). Although 
a clearly detectable population of these cells was positive for 
either IFN-γ or IL-17, their frequencies did not change under 
conditions of eosinophil deficiency (Fig. S2 H). The depletion 
of eosinophils with anti–IL-5, or by diphtheria toxin adminis-
tration to Eo-CreDtr mice, confirmed the increased presence of 
colonic Th1 cells observed in PHIL mice (Fig. 3 D). The exces-
sive expression of Ifng and Il17, but not of Il4 transcripts in 
the colonic mucosa of PHIL mice, was dependent on their gut 
microbiota, as treatment with a cocktail of antibiotics reversed 
the increased expression of these cytokines (Fig. 3 E and Fig. 
S2 I). Interestingly, while the frequency of colonic eosinophils 
was not affected by the antibiotic treatment (Fig. 3 F and Fig. 
S2 J), the depletion of commensal bacteria reduced the activa-
tion state of eosinophils in WT mice as assessed by their CD11b 
and Siglec-F expression and granularity (Fig. 3 G) and reduced 
their frequency in the MLNs (Fig. 3 H). The combined results 
suggest that constituents of the gut microbiota provide a tonic 
signal to GI-associated eosinophils that presumably is necessary 
for their homeostatic function, with homeostasis defined here 
as the absence of inappropriate, potentially tissue-damaging T 
cell responses.
Eosinophils suppress T cell proliferation and cytokine 
production upon bacterial contact
Eosinophil regulatory activity is strongly dependent on GI 
microbes; we therefore asked whether GI tract eosinophils 
directly encounter live bacteria in their tissues of residence. 
We took advantage of RFP+ H. pylori that we can readily detect 
inside professional phagocytes (Arnold et al., 2017). In chron-
ically infected mice, 1–4% of gastric LP eosinophils were RFP+ 
(Fig. 4 A); some cells were found by imaging flow cytometry anal-
ysis to harbor more than one bacterium (Fig. 4 B and Fig. S3 A). 
Gastric RFP+ eosinophils were more activated than RFP− eosin-
ophils within the same stomach, as defined by their increased 
CD11b expression and higher granularity (Fig. 4 C). As H. pylori 
is a human pathogen and eosinophils are known to infiltrate the 
gastric mucosa in H. pylori–infected patients presenting with 
gastritis (McGovern et al., 1991), we asked whether human eosin-
ophils share the ability of their murine counterparts to interact 
with live H. pylori in its gastric niche. To this end, we reconsti-
tuted NSG mice with CD34+ human cord blood–derived hema-
topoietic stem and progenitor cells, infected them with RFP+ H. 
pylori, and examined their gastric LP leukocyte populations. 
We indeed detected human CD33+ HLA-DR− Siglec-8+ eosino-
phils in the gastric LP of infected as well as control mice; in fact, 
eosinophils made up ∼15% of all hCD45+ cells in the gastric LP, 
and a fraction of them were RFP+ in mice infected with fluores-
cent H. pylori (Fig. 4 D and Fig. S3 B). Human RFP+ eosinophils 
were more activated than RFP− eosinophils in the same stom-
ach, as judged by their granularity as well as their expression 
of CD66b (a human myeloid-specific activation marker) and 
Siglec-8 (Fig. 4 D).
We next addressed in vitro whether bacterial encounter stim-
ulates regulatory activities in murine eosinophils. We differen-
tiated eosinophils in vitro from murine WT BM, which yielded 
eosinophil cultures of >90% purity as judged by flow cytometric 
analysis using SiglecF as lineage marker (Fig. S3 C), and exposed 
them to live H. pylori before co-culturing with T cells. H. pylori–
educated, but not naive eosinophils, suppressed anti-CD3/CD28–
induced T cell proliferation; this effect was observed with two 
different patient isolates of H. pylori (Fig. 4 E) and was strongest 
Figure 1. Comparative analysis of the evolution and composition of the murine GI LP eosinophil population at steady-state and during H. pylori 
infection. (A) Frequencies (in percent of live CD45+ leukocytes) and absolute counts per organ of CD11b+MHC II−Ly6G−Siglec-F+ eosinophils in the three indi-
cated compartments in 8-wk-old mice. n = 6–8; STO, stomach; SI, small intestine; CO, colon. (B) Absolute eosinophil counts per organ at the indicated age (in 
weeks). n = 4–5 per time point, shown as mean + SEM. (C–L) Eosinophil recruitment to, and activation in, the H. pylori–infected gastric LP at 6 and 12 wk post 
infection (p.i.), as assessed by flow cytometry and RNA sequencing. (C) Absolute numbers of CD45+ leukocytes in the gastric LP; n = 10–15, pooled from two 
independent studies. (D) Absolute numbers of the indicated gastric LP leukocyte populations of the mice shown in C. (E) Gastric LP eosinophil numbers and 
frequencies of the mice shown in C. (F) Frequencies of eosinophils in the BM of the mice shown in C, shown with representative FACS plots of eosinophils as 
identified by their Siglec F staining and granularity and back-gated into FSC/SSC plots of all CD45+ live cells. Lineage markers include CD3, CD4, B220, TCRα/β, 
NK 1.1, Ter119, and GR1. (G) Frequencies of eosinophils in the MLNs of the mice shown in C; representative FACS plots show the same gates as in F. In C–G, four 
and eight control mice were age-matched to the 6- and 12-wk infection, respectively. (H) Activation state of the gastric LP eosinophils shown in E, as assessed 
by CD11b and Siglec-F expression and side scatter. MFI, mean fluorescence intensity. (I) Frequencies of degranulated eosinophils as identified by their CD63 
expression, of all gastric LP eosinophils at 12 wk p.i. (J) Frequencies of apoptotic eosinophils as identified by Annexin V binding, of all gastric LP eosinophils 
at 12 wk p.i. relative to controls, shown with representative FACS plots. (K) Heat map of the top 100 most differentially regulated transcripts in FACS-sorted 
gastric LP eosinophil samples from nine infected relative to six naive mice. (L) Selected log2 expression ratios of transcripts potentially associated with either 
regulatory or pro-inflammatory functions of eosinophils. *, P < 0.05; **, P < 0.01; ***, P < 0.001, as calculated by Mann-Whitney test. Horizontal lines in scatter 
plots indicate medians throughout. Each symbol represents one mouse.
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at high eosinophil:T cell ratios (Fig. 4 F). The suppressive activ-
ity of eosinophils required their direct contact with H. pylori, as 
the separation of bacteria and eosinophils by a trans-well filter 
abrogated the effect (Fig. 4 G). The interaction of H. pylori with 
its target cells is facilitated by the Cag-pathogenicity island (PAI)–
encoded type IV secretion system (T4SS; Kwok et al., 2007). Our 
observation that CagE-deficient or Cag-PAI–deficient H. pylori, 
which both fail to assemble a functional T4SS, are less potent at 
inducing T cell–suppressive activities in eosinophils than their 
isogenic WT strains (Fig. 4 G) further underscores the contact 
dependency of the effect. Eosinophil-driven T cell suppression 
was independent of the enzyme indoleamine-pyrrole 2,3-dioxy-
genase (IDO; data not shown), but was partly abrogated by PD-L1 
neutralization (Fig. 4 H and Fig. S3 D). Along the same line, we 
found that in vitro H. pylori–educated eosinophils displayed ele-
vated expression of PD-L1 (Fig. 4 I). To assess the T cell suppres-
sive activity of eosinophils directly ex vivo, we cultured sorted 
splenic eosinophils with T cells and measured T cell proliferation 
upon CD3/CD28 activation. Similar to BM-derived eosinophils, 
splenic eosinophils inhibited T cell proliferation only if they 
had previously been exposed to live H. pylori (Fig. S3 E). To test 
whether H. pylori–educated eosinophils suppress cognate anti-
gen-induced T cell activation, we co-cultured eosinophils with 
ovalbumin-pulsed BM-derived APCs plus ovalbumin-specific 
CD4+ T cells (OT-II). H. pylori–educated, but not control eosino-
phils, suppressed the production of IFN-γ by OT-II cells (Fig. S3 F).
Having observed that activated eosinophils express high 
levels of PD-L1 and that PD-L1 neutralization at least partly 
abrogated eosinophil-driven T cell suppression (Fig.  4, H and 
I), we asked whether PD-L1 blockade would affect eosino-
phil activity and T cell responses in the steady-state colon. 
Mice that had been treated with anti–PD-L1 antibody for 1 wk 
exhibited normal eosinophil frequencies, but strongly reduced 
eosinophil-specific expression of PD-L1 itself, as well as of the 
activation and degranulation markers Siglec-F and CD63 (Fig. 
S3, G and H). Although CD4+ and CD8+ T cell frequencies were 
normal, their expression of IFN-γ was increased upon PD-L1 
blockade (Fig. S3, I and J). In conclusion, we found that eosin-
ophils in the GI tract robustly suppress proliferation and cyto-
kine production by T cells, with PD-L1 expression emerging as 
a potentially useful marker for GI tract eosinophils with regu-
latory properties.
The regulatory function of eosinophils depends on 
IFN-γ signaling
We have previously identified IFN-γ as a major determinant of 
the outcome of the H. pylori–host interaction (Sayi et al., 2009; 
Arnold et al., 2011). Furthermore, IFN-γ is a known regulator of 
PD-L1 expression in various cell types. Because H. pylori–edu-
cated eosinophils expressed higher amounts of PD-L1 (Fig. 4 I), 
we cultured H. pylori–educated eosinophils in the presence or 
absence of IFN-γ and monitored their gene expression by tar-
geted qRT-PCR. In addition to Pdl1, several additional IFN-γ tar-
get genes including Cxcl10 (encoding IP10), Stat1, Ido1, and Ccl5 
were up-regulated by H. pylori in the presence of IFN-γ in WT, 
but not Ifngr1−/− eosinophils (Fig.  5 A). With the exception of 
Stat1, the up-regulation of all transcripts required the presence 
of H. pylori in addition to IFN-γ (Fig. 5 A). The same transcripts 
were up-regulated in eosinophils sorted from the gastric LP of H. 
pylori–infected mice, whereas the expression of Ifngr1 itself was 
unaffected by exposure to H. pylori (Fig. 5, B and C). Additional 
transcripts up-regulated upon H. pylori exposure of eosinophils 
in vitro, i.e., those encoding TNF-α, IL-1β, and Cox-2 did not show 
the same strict dependence on IFN-γR signaling and also were 
not differentially regulated in eosinophils from infected relative 
to uninfected mice (Fig. S4, A and B).
We next set out to address whether the regulatory function of 
eosinophils depends on cell-intrinsic IFN-γR signaling. To this 
end, Eo-Cre mice were crossed with Ifngrfl/fl mice to obtain eosin-
ophil-specific conditional IFN-γR knockout mice. The fidelity of 
eosinophil-specific Cre expression was addressed using Eo-Cre × 
Rosa26Rfp reporter mice, which confirmed that all RFP+ cells in the 
gastric LP of Eo-Cre × Rosa26Rfp mice were eosinophils as defined 
by their expression of Siglec-F (Fig. S4 C). However, only half of 
all Siglec-F+ eosinophils were RFP+, both in the steady-state and 
during H. pylori infection (Fig. S4 D), indicating that the peroxi-
dase promoter driving Cre expression is active in only 50% of all 
gastric eosinophils. Furthermore, the RFP+ (peroxidase express-
ing) fraction of eosinophils was more likely to become activated 
upon H. pylori infection than their RFP− counterparts (Fig. S4 E).
Figure 2. The antibody-mediated or genetic depletion of eosinophils enhances Th1 and Th17, as well as innate immune responses to H. pylori and 
improves clearance of the infection. (A–C) Mice were infected with H. pylori and treated with either anti–IL-5 or isotype control antibody for 8 wk. (A) The 
eosinophil depletion efficiency was ∼80%, as shown in representative FACS plots of gastric LP leukocyte preparations. (B) Gastric mucosal expression of Ifng 
and Il17 as determined by qRT-PCR and normalized to Hprt. Data are pooled from two independent experiments. (C) H. pylori colonization of the mice shown in 
B. (D–I) Eosinophil-deficient PHIL mice were infected with H. pylori for 12 wk. (D) The gastric eosinophil depletion efficiency in PHIL mice was >95%, as shown 
in representative FACS plots (left) and for all mice of the study relative to uninfected WT controls. (E) Neutrophil and CD4+ T cell numbers in the gastric LP of 
infected WT and PHIL mice, relative to uninfected WT controls. (F) Th1 and Th17 cell frequencies in the gastric LP of infected WT and PHIL mice. (G) Gastric 
mucosal expression of Ifng and Il17 as determined by qRT-PCR and normalized to Hprt. (H) H. pylori colonization of the mice shown in D–G. Data in D–H are 
representative of two independently conducted experiments. (I) Gastric mucosal expression of the indicated transcripts, as determined by qRT-PCR and nor-
malized to Hprt. Note that PHIL mice were infected for 6 or 12 wk, whereas the anti–IL-5 treatment could only be continued for up to 8 wk. (J–L) Neonatal WT 
or PHIL mice were intrahepatically reconstituted at birth with BM from WT or PHIL donors, infected at 4 wk of age with H. pylori and sacrificed 6 wk later. (J) 
Eosinophil numbers in the gastric LP of reconstituted, infected mice, relative to nonreconstituted, infected PHIL mice. (K and L) Th1 and Th17 cell frequencies 
and H. pylori colonization of the mice shown in J. (M) Representative immunofluorescence microscopy images of FFPE sections of a control (left) and a 12 
wk-infected (H. pylori PMSS1, right) WT stomach, stained with antibodies specific for EPX (for eosinophils) and CD3 (for T cells), along with the quantification 
of eosinophil and T cell counts per 0–225 mm2. Bars, 10 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001, as calculated by Mann-Whitney test.
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Figure 3. Eosinophil depletion enhances colonic microbiota-dependent Th1 responses. (A) GI tissues from six WT and five PHIL mice were analyzed by 
qRT-PCR for the expression of Ifng, Il17, and Il4, normalized to Hprt. STO, stomach; SI, small intestine; CO, colon. (B and C) Th1, Th17 and Th2 frequencies in the 
colonic LP of 6-wk-old WT and PHIL mice at steady-state, as assessed by intracellular cytokine staining (B) and staining for the lineage-specific transcription 
factors T-bet, RORγt, and GATA-3, shown with representative FACS plots (C). (D) Th1 and Th17 cell frequencies in the colonic LP of WT mice treated with anti–
IL-5 or isotype control antibody for 10 d and of WT and Eo-CreDtr mice treated with diphtheria toxin (DT) for four days. Data are representative of two to three 
independent experiments. (E) Colonic mucosal expression of the indicated cytokines, of mice that were subjected to a 7-wk regimen of bacterial eradication by 
quadruple antibiotic therapy relative to untreated controls. (F) Eosinophil frequencies in the colons of the mice shown in E. (G) Activation state of the colonic 
LP eosinophils shown in F. (H) Eosinophil frequencies in the MLNs of the mice shown in E–G. Data are representative of two independent experiments. *, P < 
0.05; **, P < 0.01; ***, P < 0.001, as calculated by Mann-Whitney test.
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Figure 4. Eosinophils encounter RFP+ H. pylori in the gastric LP and suppress T cell proliferation in a PD-1/PD-L1–dependent manner. (A–C) Mice 
were infected at 1 wk of age with RFP+ or WT (RFP−) H. pylori for 3 mo. (A) Frequency of RFP+ eosinophils among all gastric LP eosinophils. Representative 
FACS plots are shown along with the quantification of two pooled experiments. (B) Representative ImageStream-derived image of a SiglecF+ eosinophil that 
colocalizes with multiple RFP+ bacteria. Bar, 7 µm. (C) Activation state of RFP+ relative to RFP− eosinophils of the same stomach of the mice shown in A. (D) 
Mice were reconstituted at birth with human cord blood HSCs and infected at 4 wk of age with RFP+ H. pylori for 6 wk; frequencies of human eosinophils among 
all human CD45+ leukocytes, and of RFP+ human eosinophils among all human gastric LP eosinophils are shown in the top panel. The MFI of the RFP channel 
is also shown. Bottom panel: activation state of RFP+ relative to RFP− human eosinophils of the same stomach, as judged by CD66b and Siglec-8 expression 
and granularity. (E–H) Naive or H. pylori–infected, in vitro differentiated eosinophils were co-cultured at 1:1 or the indicated ratios with CSFE-labeled immu-
nomagnetically isolated splenic CD4+ T cells in the presence of anti-CD3/CD28-coated beads, IL-2, and IL-5. Two different strains of H. pylori (PMSS1 and G27) 
were used in parallel to infect eosinophil cultures for 18 h. (E) Representative FACS plots of the CFSE dilution of anti-CD3/CD28 bead-activated T cells relative 
to T cells co-cultured with naive or H. pylori–educated eosinophils. (F) Quantification of the CFSE dilution of T cells co-cultured with the indicated eosinophil:T 
cell ratios. (G) Quantification of the CFSE dilution of T cells co-cultured with eosinophils that had previously been exposed to the indicated WT and mutant H. 
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Interestingly, Eo-Cre × Ifngrfl/fl mice mirrored the phenotype 
of eosinophil-deficient PHIL mice and exhibited higher frequen-
cies of Th1 cells, more abundant mucosal Ifng transcripts, and 
significantly lower H. pylori colonization at both 6 and 12 wk 
after infection than control mice (Fig. 5 D-F). The eosinophil-spe-
cific loss of IFN-γR abrogated the H. pylori–induced increase of 
PD-L1 expression (Fig. 5 G). In vitro exposure of eosinophils to 
both H. pylori and IFN-γ confirmed that the cytokine has a major 
impact on PD-L1 expression, which is further enhanced by H. 
pylori (Fig. 5 H).
Finally, to assess whether the eosinophil-specific loss of 
IFN-γR signaling compromises other eosinophil functions, we 
subjected Eo-Cre × Ifngrfl/fl, PHIL and WT mice to allergic sen-
sitization and challenge with house dust mite allergen. Whereas 
PHIL mice were protected against eosinophil-dependent hall-
marks of allergic asthma, Eo-Cre × Ifngrfl/fl mice did not differ 
from their WT littermates with respect to lung inflammation, 
airway eosinophilia, and goblet cell hyperplasia (Fig. 5, I–L). We 
conclude that eosinophil activity is regulated by IFN-γ in Th1/
Th17-driven, but not Th2-driven conditions and pathologies.
Eosinophils suppress Th1 and Th17 responses in an acute 
infection model
To address the function of GI-associated eosinophils in a second 
bacterial infection model, we challenged PHIL and WT mice with 
the murine attaching/effacing intestinal pathogen C. rodentium, 
which colonizes the mucosa of cecum and colon and dissemi-
nates to the MLNs and spleen in immunocompromised mice. C. 
rodentium further induces self-limiting colitis that is both medi-
ated and controlled by the immune system. In WT mice, infection 
with C. rodentium resulted in increased frequencies and activa-
tion of eosinophils in the colon (Fig. 6 A). In eosinophil-deficient 
PHIL mice, we observed increased frequencies of neutrophils, 
Th1, and Th17 cells, as well as increased expression of transcripts 
for pro-inflammatory cytokines relative to WT controls (Fig. 6, 
B–D; and Fig. S5 A). The C. rodentium–induced expression of 
anti-microbial molecules (e.g., S1009a, CXCL1, and CXCL2) was 
enhanced in PHIL mice (Fig. S5 A). Thus, the regulatory fea-
tures of eosinophils seem independent of the type of bacterial 
infection and may represent a function of general importance. 
We further observed more severe C. rodentium–induced colitis 
in PHIL mice (Fig. 6, E and F; and Fig. S5 B), which is in agree-
ment with their stronger immune activation. Unexpectedly, the 
bacterial load in the cecum and colon of PHIL mice was higher 
than in WT mice (Fig. 6 G), which suggested an additional role 
for eosinophils in C. rodentium clearance that was not observed 
with H. pylori. Indeed, C. rodentium effectively triggered eosin-
ophil degranulation and peroxidase release in vivo as assessed 
by CD63 expression and the release of EPX into the supernatants 
of colonic explants cultured ex vivo, respectively (Fig. 6, H and 
I). Interestingly, the above mentioned conditional strain lack-
ing IFN-γR signaling in the eosinophil compartment shared the 
defect of PHIL mice with respect to C. rodentium clearance, a fea-
ture that could be attributed to its inability to release EPX (Fig. 6, 
J and K). Overall, the results from the second bacterial challenge 
model used here confirm the dominant regulatory activity of 
eosinophils also during an acute infection and further highlight 
a major role of eosinophils as effector cells contributing to the 
clearance of some bacterial species, but not others.
Eosinophils contribute to bacterial clearance through the 
formation of extracellular traps
To address whether eosinophils are capable of killing C. roden-
tium and/or H. pylori in vitro, we differentiated eosinophils from 
murine BM, FACS-sorted them to >99% purity, and co-cultured 
them with either C. rodentium or H. pylori for 6 or 18 h, after 
which the bacterial viability was determined by live/dead stain-
ing and FACS analysis. As expected based on the in vivo data, C. 
rodentium, but not H. pylori, was highly susceptible to killing by 
eosinophils in this in vitro assay (Fig. 7 A). Reduced C. rodentium 
viability coincided with eosinophil degranulation as judged by 
CD63 expression, as well as the release of EPX (Fig. 7, B and C). The 
formation of eosinophil extracellular traps (EETs) was induced 
by C. rodentium, but not H. pylori (Fig. 7 D). The dissolution of 
EETs by DNase treatment abrogated the bactericidal activity of 
eosinophils toward C. rodentium (Fig. 7 D and Fig. S5, C and D). C. 
rodentium–induced EETs formed independently of the enzyme 
peptidylarginine deiminase 4 (PAD4), which deiminates histone 
H3 and H4 and is required for extracellular trap formation by 
neutrophils (data not shown; Hemmers et al., 2011). To address 
whether EETs are released in response to either bacterium in 
vivo, we stained formalin-fixed paraffin-embedded (FFPE) sec-
tions for EPX and with propodium iodide (PI) to visualize EETs 
as described previously (Yousefi et al., 2008). We observed that 
eosinophils were more abundant in the C. rodentium–infected 
relative to uninfected colonic LP and showed evidence of degran-
ulation and EET formation. Co-localization of EPX with EETs 
was also observed (Fig. 7 E). In contrast, we found no evidence of 
eosinophil degranulation (i.e., non–cell-associated EPX) or EET 
formation (nonnuclear PI) in the stomachs of H. pylori infected 
mice (Fig. 7, F and G). The combined results indicate that expo-
sure of eosinophils to C. rodentium or its components, but not to 
H. pylori, provides a stimulus for eosinophil degranulation and 
EET formation, resulting in bacterial killing.
Discussion
The role of eosinophils in the control of bacterial infections, and 
of bacterially induced immunopathology, has to date remained 
largely unexplored. We show here that the frequencies of 
pylori strains, with and without separation by a trans-well filter. (H) Quantification of the CFSE dilution of T cells in eosinophil co-cultures, in the presence or 
absence of the indicated concentrations of anti–PD-L1 blocking antibody. Means +SEM of three technical replicates of one representative experiment of two 
or three are shown in F–H. (I) PD-L1 expression of eosinophils infected with the indicated H. pylori strains for 18 h. Statistics were calculated by Mann-Whit-
ney test in A–D and by one-way ANO VA with Bonferroni’s correction in F–I and are relative to the control condition. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 5. IFN-γ signaling conditions eosinophils to suppress Th1 responses, but is not required for the pathogenic functions of eosinophils in allergic 
asthma. (A) In vitro differentiated WT or Ifngr−/− eosinophils were co-cultured for 18 h with H. pylori PMSS1 (multiplicity of infection of 10) with or without 
20 ng/ml rIFN-γ and subjected to qRT-PCR of the indicated transcripts. Means of three technical replicates + SEM are shown for one representative of two 
experiments. (B and C) Gastric LP eosinophils were FACS-sorted from naive and H. pylori–infected (6 wk) mice and subjected to qRT-PCR of the indicated 
transcripts. n = 6–8. (D–G) Eo-Cre+ × Ifngrfl/fl mice and their Cre-negative littermates (WT) were infected with H. pylori for 6 or 12 wk. (D) Th1 and Th17 cell 
frequencies in the gastric LP of infected WT and EoCre+ × Ifngrfl/fl mice. (E) Gastric mucosal expression of Ifng and Il17 as determined by qRT-PCR. (F) H. pylori 
colonization of the mice shown in D and E. (G) PD-L1 expression on gastric LP eosinophils at 12 wk p.i., as assessed by FACS of leukocyte preparations. 6-wk 
time point data are pooled from two independent studies; 12-wk time point data are representative of two experiments. (H) In vitro differentiated eosinophils 
were infected with the indicated strains of H. pylori and/or cultured in the presence of 20 ng/ml rIFN-γ for 18 h. PD-L1 expression as assessed by FACS is 
shown. (I–L) Eo-Cre+ × Ifngrfl/fl mice, their Cre-negative littermates, and PHIL mice were sensitized and challenged with house dust mite allergen. (I) Total 
leukocytes in 1 ml of bronchoalveolar lavage fluid (BALF). (J) Total eosinophils in 1 ml of BALF. (K and L) Pulmonary inflammation and goblet cell metaplasia, as 
assessed on stained lung sections. BM, basal membrane. Results in I–L are pooled from two experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001, as calculated 
by Mann-Whitney test (B–K) or by one way ANO VA with Bonferroni’s correction (A).
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mucosal Th1 cells are strongly increased in the absence of eosin-
ophils under three very different experimental conditions (i.e., 
in the steady-state colon, during acute infection of cecum and 
colon, and during chronic infection of the stomach). Eosinophils 
appear to rather selectively target Th1 responses and have no or 
only inconsistent suppressive effects on Th2 and Th17 cells in our 
hands; in contrast, Sukagawa et al. have observed the preferen-
tial down-regulation of Th17 cells by small intestinal eosinophils 
Figure 6. Eosinophils suppress C. rodentium–specific Th1 and Th17 responses and colitis. (A–H) PHIL mice and their WT littermates were infected with 
C. rodentium for 12 d. (A) Colonic LP eosinophil numbers of infected PHIL and WT relative to naive WT mice and their activation state. (B) Colonic neutrophil 
and CD4+ T cell numbers of the mice shown in A. (C) Th1 and Th17 cell frequencies in the colonic LP of C. rodentium–infected mice. (D) Cytokine and inflamma-
tory gene expression in the colonic mucosa of C. rodentium–infected mice as determined by qRT-PCR. (E and F) C. rodentium–induced colitis as assessed by 
histopathological examination of H&E-stained sections. Representative sections of C. rodentium–infected WT and PHIL mice are shown in E, along with colitis 
scores in F. (G) C. rodentium colonization of the colons and cecums of the mice shown in A–E. (H) EPX expression in the colonic mucosa of the mice shown in 
A–G, as assessed by ELI SA. Data in A–H are representative of two independent experiments. (I) CD63 expression as a marker of eosinophil degranulation, as 
assessed by FACS of colonic leukocyte preparations from the naive and C. rodentium–infected mice shown in A–H. (J and K) Eo-Cre+ × Ifngrfl/fl mice and their 
Cre-negative (WT) littermates were infected with C. rodentium for 12 d and assessed with respect to their colonization levels (J) and EPX expression in the 
colon as assessed by ELI SA (K). Bar, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001, as calculated by Mann-Whitney test. 
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Figure 7. Eosinophils contribute to C. rodentium, but not H. pylori control through degranulation and extracellular trap formation. (A) In vitro differ-
entiated eosinophils were co-cultured with either C. rodentium or H. pylori for 6 or 18 h; bacterial viability was determined by live/dead staining and FACS. 
(B) CD63 expression as a marker of eosinophil degranulation, as assessed by FACS of in vitro infected and naive eosinophil cultures. (C) EPX expression, as 
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at steady-state and have linked this phenomenon to the suppres-
sion of Th17 differentiation (Sugawara et al., 2016). While we 
have in some experiments also detected a significant expansion 
of the Th17 compartment due to eosinophil depletion, the effects 
on Th1 cells were stronger and generally more consistent. We did 
not observe clear differences in Th1 or Th17 frequencies in the 
MLNs due to the absence of eosinophils (data not shown) and 
therefore conclude that eosinophils control Th1 expansion in the 
tissue rather than their priming in the draining lymph nodes.
The regulatory capacity of eosinophils toward Th1 cells 
depends at least in part on their PD-L1 expression, but, as 
observed in the H. pylori infection model, is not necessarily asso-
ciated with degranulation. Consistent with their preference for 
Th1 cells, we found that eosinophils are cell-intrinsically condi-
tioned by IFN-γ levels in their residential tissues; IFN-γ signaling 
is required for PD-L1 expression and T cell suppression and other 
regulatory activities, but not for their detrimental functions in 
an (eosinophil dependent) model of house dust mite–induced 
allergic asthma, a pathology that is clearly driven by Th2 cells. 
The cellular sources that provide the first wave of IFN-γ and thus 
condition eosinophils in their tissues of residence are not known; 
IFN-γ–producing ILCs, which are abundant in the steady-state 
colon, may potentially serve as an important source of IFN-γ in 
that tissue. Direct contact between PD-L1–expressing eosino-
phils and PD-1+ T cells in the inflamed mucosa likely accounts 
for some of the suppressive activity; other immunomodulatory 
determinants expressed by eosinophils (such as prostaglandin E2 
synthase/cyclooxygenase 2 and its product PGE2, or transforming 
growth factor β, TGF-β) may additionally contribute to the overall 
phenotype. We could not substantiate a critical role for IDO and 
tryptophan metabolism, at least in in vitro suppression assays. 
Our results are consistent with a previous study conducted on 
purified human eosinophils that also documented IFN-γ–depen-
dent effects on eosinophil effector functions such as their degran-
ulation and superoxide production (Yamaguchi et al., 2008). We 
hypothesize that the relative abundance of eosinophils in the GI 
tract (their largest reservoir in the body), and their strict regu-
lation by IFN-γ, has specifically evolved to restrict inappropriate 
Th1 responses to bacterial commensals and pathogens in the con-
text of type 1 immunity.
Interestingly, we found that eosinophils directly encounter 
bacteria (or at least their protein products) in infected GI tract 
tissues. A substantial fraction of murine eosinophils, as well as 
human eosinophils in mice reconstituted with a human immune 
system, were positive for RFP when exposed to RFP-expressing 
bacteria. Eosinophils that had come in contact with H. pylori 
were generally more activated than their naive counterparts 
in the same stomach, and eosinophils from infected tissues 
exhibited dramatically different gene expression profiles than 
steady-state eosinophils as judged by RNA sequencing of sorted 
populations. Many of the transcripts identified in the RNA 
sequencing approach could subsequently be validated, and were 
synergistically regulated by a bacterial (H. pylori) signal in con-
junction with IFN-γ. Neither signal alone was sufficient to drive 
differential gene expression, and only synergistically activated 
transcripts could be confirmed in vivo. These data indicate that 
eosinophil activity in tissues is tightly controlled, preventing 
inappropriate degranulation on the one hand, and Th1-driven 
immunopathology on the other. The regulation of eosinophil 
activity by a microbial stimulus, in conjunction with a strongly 
tissue-damaging cytokine such as IFN-γ, thus is consistent with 
their critical role in tissue homeostasis within the GI tract.
In contrast to H. pylori, which activates eosinophils without 
triggering their degranulation and EET formation and therefore 
is protected from eosinophil bactericidal activities, the pathogen 
C. rodentium is readily killed by eosinophils in vitro, and colo-
nizes the murine colon and cecum at much higher levels in their 
absence. Candidate eosinophil citrobactericidal factors are ECP 
and MBP, which both were shown to be associated with EETs (von 
Köckritz-Blickwede and Nizet, 2009) and, in very early work, to 
have bactericidal activity in vitro (Lehrer et al., 1989; Rosenberg 
and Dyer, 1995). The deployment of EETs protects mice against 
sepsis in vivo and has been proposed as an essential mechanism 
maintaining intestinal barrier function in the face of inflam-
mation-associated epithelial cell damage (Yousefi et al., 2008). 
Among the few bacterial species with documented susceptibility 
to eosinophil killing in vitro and in vivo is Pseudomonas aerugi-
nosa (Linch et al., 2009). The fact that the citrobactericidal activ-
ities of eosinophils are abrogated by DNase treatment implicates 
EETs and their associated granule factors.
The concept that eosinophils have roles in homeostasis, 
tissue protection and the prevention of immunopathology is 
slowly gaining more attention (Rosenberg et al., 2013; Travers 
and Rothenberg, 2015; Wen and Rothenberg, 2016). In the lung, 
a resident eosinophil subset has been identified that possesses 
regulatory activities, is phenotypically distinct from the inflam-
matory eosinophils that are recruited in an IL-5–dependent 
manner during allergen-induced asthma, and in fact suppresses 
allergen-specific Th2 responses by inhibiting the maturation of 
allergen-loaded DCs (Mesnil et al., 2016). It is tempting to spec-
ulate in this context that the two (EoCre+ and EoCre−) eosinophil 
populations that we have identified in the GI tract correspond to 
such specialized subsets, although both subsets are depleted in 
PHIL mice and by anti–IL-5 treatment. In the GI tract, two recent 
assessed by ELI SA of the supernatants of eosinophil cultures. (D) Eosinophil extracellular trap (EET) formation by eosinophils infected with C. rodentium, but 
not H. pylori; white arrowheads point to bacteria caught in EETs. DNase I treatment dissolves EETs. (E and F) Representative confocal immunofluorescence 
microscopy images of FFPE sections of a C. rodentium–infected colon (12 d, E) and an H. pylori–infected stomach (12 wk, F), along with uninfected control 
sections of both tissues (EPX, green; propidium iodide, PI, red). Arrows point to regions of high eosinophil density and of colocalized extracellular EPX and 
EETs. The quantification of eosinophils in C. rodentium–infected colons is shown in E. Bars, 50 µm in low magnification (orange), 10 µm in high magnification 
images (white). (G) Quantification of eosinophils with EETs in stomachs and colons of four H. pylori–infected and four C. rodentium–infected mice relative to 
their uninfected controls. Statistics were calculated by Mann-Whitney test in A–E and by one-way ANO VA with Bonferroni’s correction in G. *, P < 0.05; **, P 
< 0.01; ***, P < 0.001.
Arnold et al. 
Regulatory function of eosinophils in infection
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20172049
14
reports have highlighted homeostatic properties of eosinophils, 
which could be attributed to their role in promoting the differ-
entiation of IgA-expressing plasma cells and class switching to 
IgA, as well as the maintenance of intestinal mucus secretion 
and the development of Peyer's patches (Chu et al., 2014; Jung et 
al., 2015). Consequently, mice lacking eosinophils had a clearly 
altered intestinal microbial composition (Chu et al., 2014; Jung et 
al., 2015). These data are in good agreement with our own results 
showing that T cell responses directed against the normal colonic 
and cecal microbiota are under tight eosinophil control at steady-
state. Overall, our results add to a growing body of evidence that 
attributes beneficial functions in homeostasis and immune reg-
ulation to this poorly understood cell type.
Materials and methods
Animal experimentation
C57BL/6J (stock 000664), Ifngr1fl/fl (stock 025394), Ifngr1−/− 
(stock 003288), OT-II (Stock 004194), and NSG (Stock 005557) 
mice were obtained from the Jackson Laboratory. B6-Gt(RO-
SA)26Sortm1(Dtr)ThBu (iDTR) mice were described previously (Buch 
et al., 2005). B6-Gt(ROSA)26Sortm1(Rfp) (Rosa26Rfp) mice were 
obtained from a local mouse repository. Eosinophil-deficient 
mice (PHIL; Lee et al., 2004) and mice expressing Cre under the 
EPX promoter (EoCre; Doyle et al., 2013) were obtained from J.J. 
Lee (Mayo Clinic, Phoenix, AZ). All strains were bred and main-
tained under specific pathogen-free conditions in accredited 
animal facilities at the University of Zürich. Mice were included 
in experiments at 5–6 wk of age; breeding pairs were set up so 
that female breeders were phenotypically WT, and each litter was 
internally controlled. Breeding pairs were renewed every second 
generation. For the depletion of eosinophils, WT mice were i.p. 
injected two times per week with 0.25 mg of anti–IL-5 antibody 
(TREK5; BioXCell) or with anti–horseradish peroxidase isotype 
control antibody (HRPN; BioXCell) starting from the day of infec-
tion. For short-term diphtheria-toxin (DT)–mediated eosinophil 
depletion, Eo-Cre × iDTRfl/+ mice were treated on four consecu-
tive days with 15 ng/g body weight DT (Sigma). PD-L1 blocking 
antibody (10F.9G2’ BioXcell) was administered twice with a 3-d 
interval at 0.5 mg/mouse. For eosinophil reconstitution experi-
ments, newborn PHIL or WT mice were sub-lethally irradiated 
with 1.3 Gy and injected intra-hepatically with 1.5 × 106 adult 
BM cells 3 d after birth. Mice were infected with H. pylori 4 wk 
after reconstitution and analyzed 6 wk later. For the generation 
of humanized mice, newborn NSG mice were sub-lethally irra-
diated with 1.3 Gy and injected intra-hepatically with 1.5 × 105 
human CD34+ hematopoietic stem cells (HSCs) 3 d after birth. 
CD34+ cells were isolated from human cord blood with immu-
nomagnetic beads (Miltenyi Biotec) with a yield of 0.5–4 × 106 
CD34+ cells per donor (purity >90%) and were stored in liquid 
nitrogen until use. Mice were infected with H. pylori 3 wk after 
reconstitution and analyzed 10 wk later. For the depletion of gut 
commensal microbiota, animals were given ampicillin (1 g l−1; 
Sigma), vancomycin (500 mg l−1; Applichem), neomycin sulfate 
(N; 1 g l−1; Applichem), and metronidazole (1 g l−1; Sigma) in their 
drinking water for 7 wk as described (Diehl et al., 2013) before 
analysis. For the induction of house dust mite–induced allergic 
asthma, mice were sensitized on day 0 (1 µg) and challenged on 
days 8–12 (15 µg) intranasally with house dust mite extract (Greer 
Laboratorie; XPB70D3A25 Dermatophagoides pteronyssinus). 
On day 15, mice were sacrificed, and lungs were lavaged with PBS 
via the trachea. Broncho-alveolar lavage fluid (BAL) cells were 
counted using trypan blue dye exclusion. Differential cell counts 
of macrophages, lymphocytes, neutrophils, and eosinophils were 
performed on cytospins stained with the Microscopy Hemacol-
or-Set (Merck). For lung histopathology, lungs were fixed by 
inflation and immersion in buffered 10% formalin and embedded 
in paraffin. Tissue sections were stained with H&E and periodic 
acid-Schiff (PAS) and examined in blinded fashion. Peribronchial 
and perivascular inflammation was scored on a scale from 0 to 
4. PAS-positive goblet cells were quantified per 1 mm of base-
ment membrane. All animal experimentation was reviewed and 
approved by the Zürich Cantonal Veterinary Office (licenses 
ZH170/2014, ZH24/2013, ZH235/2015, and ZH140/2017 to A.M.).
H. pylori strains, culture conditions and colony counting
Mice were infected orally on two consecutive days with 108 CFU 
H. pylori PMSS1 at 5 wk of age and analyzed at 6 and 12 wk p.i. 
For PMSS1 RFP+ infection of C57BL/6 mice, mice were infected 
on day 7 of age to achieve high levels of bacterial colonization 
and analyzed after 12 wk p.i. The H. pylori strain used in this 
study, PMSS1, is a clinical isolate of a patient with duodenal ulcer 
and the parental strain of the mouse-derivative Sydney strain 1 
(SS1) (Arnold et al., 2011). The PMSS1ΔCagE isogenic mutant 
was described previously (Arnold et al., 2011), as was H. pylori 
strain G27 and its G27ΔPAI isogenic mutant (Toller et al., 2011). 
The RFP-expressing PMSS1 was generated by transforming 
PMSS1 with the plasmid pTM115-RFP used previously in strain 
SS1 (Keilberg et al., 2016). H. pylori was grown on horse blood 
agar plates and in liquid culture as described previously (Arnold 
et al., 2011). Cultures were routinely assessed by light microscopy 
for contamination, morphology, and motility.
C. rodentium strains, culture conditions, and colony counting
The nalidixic acid (NAL)–resistant C. rodentium strain ICC169 
was grown overnight at 37°C in Luria broth (LB) supplemented 
with NAL (50 µg/ml; Sigma). Mice were infected orally with 5 × 
108 bacteria for 12 d. To assess C. rodentium colonization, cecal 
and colonic tissues were homogenized in PBS, diluted, and plated 
on LB plates supplemented with NAL. Colonies were counted 
after 18 h of culture at 37°C. Colonic and cecal bacterial loads were 
normalized to tissue weight.
Histological assessment of colonic inflammation
Distal colon samples were fixed in buffered 10% formalin solu-
tion. Paraffin embedded sections were stained with hematoxylin 
and eosin and the histopathology of the colon was scored in a 
blinded fashion using a scoring system considering five catego-
ries (each scored on a scale of 0–3): epithelial hyperplasia/dam-
age and goblet cell depletion; leukocyte infiltration in the lamina 
propria; submucosal inflammation and edema; area of tissue 
affected; and markers of severe inflammation such as bleeding, 
crypt abscesses, and necrosis/ulceration. The final score pre-
sented (scored 0–15) represents the sums of all categories.
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Flow cytometry, cell sorting and counting
For surface staining, cells were stained in PBS with 0.5% BSA 
with a fixable viability dye and a combination of the following 
antibodies: anti-mouse B220 (RA3-6B2), CCR3 (J073E5), CD11b 
(M1/70), CD11c (N418), CD4 (RM4-5), CD44 (IM7), CD45 (30-F11), 
CD49b (DX5), CD63 (NVG-2), F4/80 (BM8), GR-1 (RB6-8C5), IL-7R 
(A7R34), Ly6G (1A8), MHC-II (M5/114.15.2), TCR-β (H57-597), and 
Thy1.2 (53–2.1), all from BioLegend; anti-mouse IL-5R (TRFK5) 
and Siglec-F (E50-2440) from BD Biosciences; anti-mouse PD-L1 
(B7-H11) from eBioscience/Invitrogen; anti-human CD33 (P67.6), 
CD66b (G10F5), CD45 (HI30), HLA-DR (L243), and Siglec-8 (7C9), 
all from BioLegend. Fc block (anti-CD16/CD32, Affymetrix) was 
included to minimize nonspecific antibody binding. Annexin V 
staining was performed with the Annexin V Apoptosis Detection 
Set (eBioscience) according to the manufacturer's instructions. 
For intracellular cytokine staining of T cells, cells were incubated 
for 3.5 h in complete IMDM containing 0.1 µM phorbol 12-myri-
state 13-acetate and 1  µM ionomycin with 1:1,000 Brefeldin A 
(eBioscience) and GolgiStop solutions (BD Biosciences) at 37°C in 
a humidified incubator with 5% CO2. Following surface staining, 
cells were fixed and permeabilized with the Cytofix/Cytoperm 
Fixation/Permeabilization Solution kit (BD Biosciences) accord-
ing to the manufacturer's instructions. Cells were then stained 
for 50 min with antibodies to IL-17A (TC11-18H10.1), IFN-γ 
(XMG1.2), and IL-4 (11B11, all from Biolegend). For the staining of 
T cell transcription factors, cells were surface stained and fixed 
and permeabilized with the Foxp3/Transcription Factor Stain-
ing Buffer Set (eBioscience) according to the manufacturer's 
instructions. Cells were then stained for 50 min with antibodies 
to mouse Foxp3 (MF-14, Biolegend), Gata3 (TWAJ, eBioscience), 
T-bet (4B10, Biolegend) or Rorγt (Q31-378, BD Bioscience). Total 
leukocyte counts were determined by adding countBright Abso-
lute Counting Beads (Life Technologies) to each sample before 
analysis. Samples were analyzed on a LSR II Fortessa (BD Biosci-
ences) or sorted on a FACS Aria III (BD Biosciences) to a purity 
of >95%. Flow-cytometric analyses were performed using FlowJo 
software (Tree Star). Where indicated, sorted eosinophils were 
subjected to cytospin and visualized by microscopy upon staining 
with the Microscopy Hemacolor-Set (Merck).
Quantitative PCR
RNA was isolated from scraped gastric mucosa, homogenized 
colonic and intestinal tissues, BM-derived eosinophils, or from 
FACS-sorted cells using the RNeasy Mini kit (QIA GEN) accord-
ing to the manufacturer’s instructions, including an on-col-
umn DNase I digestion step. Complementary DNA synthesis 
was performed using Superscript III reverse transcription (QIA 
GEN). Quantitative PCR reactions for the candidate genes were 
performed using TaqMan Gene Expression Assays (Applied 
Biosystems by ThermoFisher Scientific): Ccl11 (Mm00441238_
m1), Ccl5 (Mm01302427_m1), Csf2 (Mm01290062_m1), 
Cxcl1 (Mm04207460_m1), Cxcl10 (Mm00445235_m1), 
Cxcl2 (Mm00436450_m1), Gata3 (Mm00484683_m1), Hprt 
(Mm03024075_m1), Ido1 (Mm00492590_m1), Ifng (Mm01168134_
m1), Ifngr1 (Mm00599890_m1), Il17a (Mm00439618_m1), Il1b 
(Mm00434228_m1), Il22 (Mm01226722_g1), Il4 (Mm00445259_
m1), Il5 (Mm00439646_m1), Il6 (Mm00446190_m1), 
Nos2 (Mm00440502_m1), Pdl1 (Mm03048248_m1), Ptgs2 
(Mm00478374_m1), Rorc (Mm01261022_m1), S100a9 
(Mm00656925_m1), Stat1 (Mm01257286_m1), Tbx21 
(Mm00450960_m1), and Tnf (Mm00443258_m1). According to 
the manufacturer’s instructions, all TaqMan Gene Expression 
Assays have been designed, optimized, and extensively tested 
to ensure equivalent amplification efficiencies of 100% (±10%) 
and therefore do not require additional efficacy measurements. 
Complementary DNA samples were analyzed using a Light Cycler 
480 detection system (Roche) with the Second Derivative Maxi-
mum method analysis with the high confidence algorithm. Gene 
expression levels for each sample were normalized to HPRT 
expression. Mean relative gene expression was determined, and 
the differences were calculated using the 2ΔC(t) method.
Leukocyte isolation
For lamina propria leukocyte isolation, GI tissues were opened 
longitudinally, washed and cut into pieces. Peyer’s patches were 
removed from the small intestine. Pieces were incubated in HBSS 
with 10% FCS and 5 mM EDTA at 37°C to remove epithelial cells. 
Gastric tissue was digested at 37°C for 50 min in a shaking incu-
bator with 15 mM Hepes, 500 U/ml of type IV collagenase (Sig-
ma-Aldrich) and 0.05 mg ml−1 DNase I in RPMI-1640 medium 
supplemented with 10% FBS and 100 U ml−1 penicillin/strepto-
mycin. Intestinal tissues were digested with an equal mixture of 
250 U/ml type IV and type VIII (Sigma-Aldrich) collagenase. Cells 
were then layered onto a 40/80% Percoll gradient, centrifuged, 
and the interface was washed in PBS with 0.5% BSA. BM cell 
suspensions were prepared by flushing the marrow out of femur 
and tibia and were resuspended in PBS with 2% BSA. MLNs were 
digested at 37°C for 20 min in a shaking incubator with 500 U/
ml of type IV collagenase and mashed through a cell strainer. 
Splenocyte suspensions were prepared by mashing the spleens 
through a cell strainer using a syringe plunger, followed by red 
blood cells lysis.
Differentiation of BM-derived eosinophils and APCs
To generate murine BM-derived myeloid cells, BM stem cells 
from donor mice were flushed from the femur and the tibia and 
were resuspended in RPMI-1640 medium upon red blood cell 
lysis. For the generation of BM-derived eosinophils (BM Eos), 
cells were seeded at a density of 106 cells/ml in RPMI-1640 
medium supplemented with 20% heat inactivated FBS, 25 mM 
Hepes, 100 U ml−1 penicillin/streptomycin, 2 mM glutamine, 1× 
NEAA, and 1 mM sodium pyruvate, and cultured at 37°C. BM 
Eos were differentiated with 100 ng/ml mouse stem cell fac-
tor (PeproTech) and 100 ng/ml mouse FLT3-Ligand (FLT3-liter; 
PeproTech) from day 0 to day 4, followed by differentiation with 
10 ng/ml mouse IL-5 (PeproTech) only from day 4 onwards, as 
described (Dyer et al., 2008). Half of the medium was changed 
every other day and the cell concentration was adjusted to 106 
cells/ml until day 14. On day 8, cells were collected and moved 
to new flasks to remove adherent contaminating cells. On day 
13, the nonadherent cells were collected washed, counted, and 
plated into a 96-well plate. Experiments were performed at 
day 14. Eosinophil purity was assessed by flow cytometry at 
day 13 and cell morphology was visualized by microscopy upon 
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cytospin and staining with the Microscopy Hemacolor-Set 
(Merck). For the generation of BM APCs, cells were seeded at 
a density of 0.7 × 106 cells/ml and differentiated with 20 ng/ml 
GM-CSF (PeproTech) for 6 d at 37°C. Cells were replated into 
96-well plates prior to being used.
In vitro eosinophil infection, co-culture experiments, EETs 
analysis, and bacterial viability assay
For in vitro infection experiments, BM eosinophils or FACS-sorted 
splenic eosinophils were washed and kept in antibiotic-free 
RPMI-1640 medium supplemented with 10% heat-inactivated 
FBS and 10 ng/ml IL-5. BM eos were seeded in round-bottom 
96-well plates at a density of 125,000 cells/well and infected with 
H. pylori or C. rodentium at 37°C for 18 h unless specified oth-
erwise. Where indicated, eosinophils were treated with recom-
binant mouse IFN-γ (20 ng/ml, Peprotech). Where indicated, H. 
pylori and eosinophils were separated by a transwell during the 
time of infection (0.4 µm pores; Corning Transwell, Sigma). Upon 
infection or treatment, cells were washed and either analyzed 
by flow-cytometry for surface markers or gene expression, or 
supplemented with 100 U ml−1 penicillin/streptomycin and 25 
mg ml−1 Kanamycin to eliminate bacterial contaminants, before 
T cell co-culture. CD4+ naive T cells were magnetically isolated 
from splenocyte suspensions with the MagCellect Mouse Naive 
CD4+ T Cell Isolation kit (R&D Systems). T cells were labeled with 
CFSE (Life Technologies) and co-cultured with eosinophils for 4 
d at a 1:1 ratio in the presence of 30 U/ml recombinant human 
IL-2 (Proleukin, Prometheus), 10 ng/ml IL-5 and mouse T-Acti-
vator CD3/CD28 Dynabeads (Life Technologies). CFSE dilution 
was assessed by flow cytometry. Where indicated, co-cultures 
were treated with anti-mouse PD-L1 (B7-H1, BioXcell). For co-cul-
ture experiments with splenic eosinophils, 40,000 FACS-sorted 
eosinophils were co-cultured as described above with 150,000 
naive CD4+ T cells. For the antigen-specific setup, 40,000 BM 
APCs were matured with LPS for 4 h, washed and loaded with 
OVA peptide 329–339 (5 × 10−5 M, PolyPeptide) 30 min before 
co-culture with 120,000 naive OTII CD4+ T cells and 40,000 
sorted splenic eosinophils, previously infected with PMSS1 for 
18 h. IFN-γ production was determined by intracellular cytokine 
staining. To determine bacterial viability upon infection of eosin-
ophils, cell cultures were resuspended and an aliquot was stained 
with the LIVE/DEAD BacLight Bacterial Viability and Counting 
kit (Molecular Probes by Life Technologies) according to the 
manufacturer’s instructions and analyzed by flow cytometry. For 
EET formation assay and DNA quantification, 100,000 BM eos 
were infected with H. pylori and C. rodentium and treated with 
DNaseI (5 U/per well) where indicated at 37°C for 20 min. Cells 
further received 5 µM/well Sytox green (Invitrogen) after 10 min 
and were analyzed for EETs formation and DNA release in the 
culture supernatants. Cells were then spun, spread onto a glass 
slide, and visualized for extra cellular trap formation on a Leica 
DM6 B microscope. To quantify the amount of released DNA, 
100 μl of culture supernatant per sample were transferred to a 
white, clear-bottom 96-well plate (Greiner Bio-One GmbH). The 
fluorescent emission intensity of DNA-bound Sytox green was 
measured on a fluorometer (SpectraMax i3, Molecular Devices) 
at 485 nm (excitation)/527 nm (emission).
Quantitation of secreted EPX
Mid-colon sections (one section per mouse) were weighed and 
cultured in RPMI 1640 medium with 10% FCS and 100 U/ml pen-
icillin/streptomycin for 24 h at 37°C in a humidified incubator 
with 5% CO2. Cell-free supernatants were stored at −80°C and 
normalized to initial tissue weight in subsequent assays. EPX was 
detected in supernatants of colon explant cultures or BM Eos cul-
tures by Sandwich/Capture ELI SA (anti-EPX capture antibody 
clone MM25-429.1.1; biotinylated anti-EPX detection antibody 
clone MM25-82.2.1), provided by J.J. Lee, as described previously 
(Ochkur et al., 2012).
RNA sequencing and data analysis
RNA from FACS-sorted gastric eosinophils was isolated using the 
Arcturus PicoPure RNA Isolation kit (Applied Biosystems, Ther-
moFisher Scientific). RNA quality was assessed by the Agilent 
Tapestation followed by library preparation using the NuGEN 
Ovation SoLo protocol. Sequencing was subsequently performed 
on the Illumina HiSeq 2500 instrument. RNA-seq reads were 
quality-checked with fastqc, which computes various quality 
metrics for the raw reads. RNA-seq reads were mapped using 
the STAR aligner to the mouse reference genome build GRCm38. 
We included the Ensembl transcript annotations in the mapping 
index. Alignments were counted according using the feature-
Counts function in the Rsubread Bioconductor package. Statis-
tical analysis of differential expression was conducted with the 
DESeq2 package. All RNA seq data generated within this study 
are publicly accessible at the Gene Expression Omnibus (GEO) 
repository (no. GSE105143).
Imaging flow cytometry
For imaging flow cytometry, cells were prepared and stained as 
for conventional flow cytometry. Cell acquisition was performed 
on the Image Stream X Mark II (Merck, Millipore). Analysis 
was performed with IDE AS software following a standard gat-
ing strategy excluding doublets, dead and CD45 negative cells. A 
g-value of 0.9 was applied to the images while setting the display 
to pixel data range.
Immunofluorescence and confocal microscopy
Paraffin-embedded tissue sections were deparaffinized and 
rehydrated with graded ethanol dilutions. After antigen retrieval 
in pressure cooker using EDTA-Tris buffer (10  mM, pH 9.0), 
immunofluorescence staining was performed by incubating the 
paraffin sections with mouse monoclonal anti-EPX antibody 
(1:300; clone MM25-82 2; obtained from Lee Laboratories, Mayo 
Clinic) and rabbit monoclonal anti-CD3 antibody (1:20; clone SP7; 
ThermoFisher Scientific, distributed by LuBioScience GmbH). 
Thereafter, secondary Alexa Fluor 488–conjugated goat anti-
mouse (1:400) and Alexa Fluor 545–conjugated goat anti-rabbit 
(1:400) antibodies (ThermoFisher Scientific) were applied and 
tissue samples incubated at RT for 1 h. To detect EETs, tissue sec-
tions were incubated with anti-EPX antibody and subsequently 
stained with PI for additional 10 min. Samples were washed and 
mounted in Prolong Gold mounting medium and image acqui-
sition was performed using confocal laser scanning microscopy 
LSM 700 (Carl Zeiss Micro Imaging) with a 20× or 40×/1.40 Oil 
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DIC objective and analyzed with IMA RIS software (Bitplane 
AG). For quantitative analysis, EPX+ and CD3+ infiltrating cells 
were counted in 10 high-power fields (hpf) of highest activity 
using an automated slide scanner (3DHI STE CH slide scanner, 
Quant Center software, using Cell Count module). To determine 
the proportion of eosinophils forming EETs, we analyzed 300 
eosinophils in each tissue section.
Statistical analysis
Statistical analysis was performed with Prism 6.0 (GraphPad 
Software). The nonparametric Mann-Whitney test was used for 
all statistical comparisons unless specified otherwise. *, P < 0.05; 
**, P < 0.01; and ***, P < 0.001.
Online supplemental material
The supplemental material associated with this manuscript con-
sists of five supplemental figures. These show the gating strategy 
used to identify eosinophils as CD45+CD11b+MHC II−Ly6G−SiglecF+ 
cells in single-cell preparations of the gastric lamina propria 
(Fig. S1) and demonstrate that the frequencies of major GI leu-
kocyte populations do not change upon eosinophil depletion in 
the steady-state and during infection (Fig. S2). The supplemental 
material further shows that cultured murine eosinophils acquire 
T cell–suppressive properties upon encountering H. pylori (Fig. 
S3), a feature that is regulated by IFN-γ (Fig. S4), and that eosin-
ophils suppress C. rodentium–induced colitis and contribute to 
bacterial clearance by extracellular trap formation (Fig. S5).
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